Basics ImmunityBio, Inc. Common Stock IPO Date: July 27, 2015 Sector: Healthcare Industry: Biotech Market Cap: $2.42B Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 4.57% Avg Daily Range (30 D): $0.08 | 2.84% Avg Daily Range (90 D): $0.09 | 3.41% Institutional Daily Volume Avg Daily Volume: 3.32M Avg Daily Volume (30 D): 7.36M Avg Daily Volume (90 D): 7.68M Trade Size Avg Trade Size (Sh.): 204 Avg Trade Size (Sh.) (30 D): 374 Avg Trade Size (Sh.) (90 D): 359 Institutional Trades Total Inst.Trades: 1,138 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $2M Avg Inst. Trade (90 D): $1.54M Avg Inst. Trade Volume: .34M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.93M Avg Closing Trade (30 D): $1.6M Avg Closing Trade (90 D): $1.39M Avg Closing Volume: 351.35K     News Jul 9, 2025 @ 12:30 PM Breaking Through: Systemic Genetic Medicines for H... Source: Prnewswire Aug 23, 2024 @ 8:30 PM HCW Biologics Reports Second Quarter 2024 Financia... Source: N/A Jun 26, 2024 @ 1:41 PM ImmunityBio (IBRX) Gains 17% in the Past Week: Her... Source: Zacks Equity Research Mar 20, 2024 @ 3:41 PM Sportradar Group Posts Upbeat Earnings, Joins King... Source: Avi Kapoor Feb 26, 2024 @ 6:57 PM Why Freshpet Shares Are Trading Higher By Around 1... Source: Avi Kapoor Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.15 $-.12 Diluted EPS $-.15 $-.14 Revenue $ $ 16.52M $ 6.11M Gross Profit $ $ 16.46M $ Net Income / Loss $ $ -129.67M $ -85.75M Operating Income / Loss $ $ -64.43M $ -80.25M Cost of Revenue $ $ .06M $ M Net Cash Flow $ $ -82.76M $ -18.15M PE Ratio